Therapeutic Solutions International, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSOI research report →
Companywww.therapeuticsolutionsint.com
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health.
- CEO
- Timothy George Dixon
- IPO
- 2008
- Employees
- 3
- HQ
- Elk City, ID, US
Price Chart
Valuation
- Market Cap
- $512.27K
- P/E
- -0.15
- P/S
- 5.17
- P/B
- 0.28
- EV/EBITDA
- -0.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 62.86%
- Op Margin
- -2006.67%
- Net Margin
- -2191.86%
- ROE
- -184.90%
- ROIC
- -91.55%
Growth & Income
- Revenue
- $98.99K · -52.12%
- Net Income
- $-2,169,814 · 43.11%
- EPS
- $-0.00 · 53.33%
- Op Income
- $-1,986,479
- FCF YoY
- -5.22%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.46
- Avg Volume
- 2.12M
Get TickerSpark's AI analysis on TSOI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 24 | DIXON TIMOTHY G | other | 55,555,555 |
| Sep 30, 24 | Ichim Thomas | other | 10,000,000 |
| Jul 11, 24 | Ichim Thomas | other | 10,000,000 |
| Jul 11, 24 | DIXON TIMOTHY G | other | 20,000,000 |
| Jul 8, 24 | Ichim Thomas | other | 10,000,000 |
| Jul 8, 24 | DIXON TIMOTHY G | other | 25,000,000 |
| May 30, 24 | Ichim Thomas | other | 10,000,000 |
| May 30, 24 | DIXON TIMOTHY G | other | 37,500,000 |
| Apr 18, 24 | DIXON TIMOTHY G | other | 42,857,142 |
| Apr 18, 24 | Ichim Thomas | other | 15,000,000 |
Our TSOI Coverage
We haven't published any research on TSOI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TSOI Report →